Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Schetelig

Showing results (1-10 of 236) with videos related to

Pageof 24
Sort By:
Blood|June 13, 2024
Unrelated donor selection with PTCyJohannes Schetelig, Martin Bornhäuser
British Journal of Haematology|August 26, 2025
Back to life: Biological parenthood of young adult acute leukaemia survivorsKatharina Egger-Heidrich, Katja Sockel, Johannes Schetelig
Bone Marrow Transplantation|June 27, 2022
Analysis of survival outcomes in haematopoietic cell transplant studies: Pitfalls and solutionsLiesbeth C de Wreede, Johannes Schetelig, Hein Putter
Oncotargets and Therapy|February 17, 2017
Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicaseNael Alakel, Jan Moritz Middeke, Johannes Schetelig, et al.
Cancer Immunology, Immunotherapy : CII|May 12, 2005
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantationJohannes Schetelig, Alexander Kiani, Marc Schmitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2011
The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the indexNicole Birninger, Martin Bornhäuser, Markus Schaich, et al.
Annals of Hematology|July 4, 2013
Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndromeJan Moritz Middeke, Normi Bruck, Stefani Parmentier, et al.
Best Practice & Research. Clinical Haematology|March 15, 2024
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS RegistryAlexander H Schmidt, Jürgen Sauter, Johannes Schetelig, et al.
Best Practice & Research. Clinical Haematology|June 23, 2023
Handling missing covariate data in clinical studies in haematologyEdouard F Bonneville, Johannes Schetelig, Hein Putter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
KIR Genotyping Data of More Than 3 Million Individuals Are Available for Global Unrelated Stem Cell Donor Searches (Comment to: Weisdorf D, Cooley S, Wang T, et al. KIR donor selection: feasibility in identifying better donors. Biol Blood Marrow Transplant. 2018; doi: 10.1016/j.bbmt.2018.08.022.)Alexander H Schmidt, Vinzenz Lange, Jan A Hofmann, et al.
Pageof 24

Showing results (1-10 of 236) with videos related to

Sort By:
Pageof 24
Blood|June 13, 2024
Unrelated donor selection with PTCyJohannes Schetelig, Martin Bornhäuser
British Journal of Haematology|August 26, 2025
Back to life: Biological parenthood of young adult acute leukaemia survivorsKatharina Egger-Heidrich, Katja Sockel, Johannes Schetelig
Bone Marrow Transplantation|June 27, 2022
Analysis of survival outcomes in haematopoietic cell transplant studies: Pitfalls and solutionsLiesbeth C de Wreede, Johannes Schetelig, Hein Putter
Oncotargets and Therapy|February 17, 2017
Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicaseNael Alakel, Jan Moritz Middeke, Johannes Schetelig, et al.
Cancer Immunology, Immunotherapy : CII|May 12, 2005
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantationJohannes Schetelig, Alexander Kiani, Marc Schmitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2011
The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the indexNicole Birninger, Martin Bornhäuser, Markus Schaich, et al.
Annals of Hematology|July 4, 2013
Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndromeJan Moritz Middeke, Normi Bruck, Stefani Parmentier, et al.
Best Practice & Research. Clinical Haematology|March 15, 2024
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS RegistryAlexander H Schmidt, Jürgen Sauter, Johannes Schetelig, et al.
Best Practice & Research. Clinical Haematology|June 23, 2023
Handling missing covariate data in clinical studies in haematologyEdouard F Bonneville, Johannes Schetelig, Hein Putter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
KIR Genotyping Data of More Than 3 Million Individuals Are Available for Global Unrelated Stem Cell Donor Searches (Comment to: Weisdorf D, Cooley S, Wang T, et al. KIR donor selection: feasibility in identifying better donors. Biol Blood Marrow Transplant. 2018; doi: 10.1016/j.bbmt.2018.08.022.)Alexander H Schmidt, Vinzenz Lange, Jan A Hofmann, et al.
Pageof 24